Evidence map›Paper›PMID 35775730›Full record

ArticleeLife2022

Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2.

Brandon Wey-Hung Liauw, Arash Foroutan, Michael R Schamber, Weifeng Lu, Hamid Samareh Afsari, Reza Vafabakhsh

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. GPCR drug discovery: new agents, targets and indications.Nature reviews. Drug discovery · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brandon Wey-Hung LiauwDepartment of Molecular Biosciences, Northwestern University, Evanston, United States.ORCID 0000-0002-6186-7092
Arash ForoutanDepartment of Molecular Biosciences, Northwestern University, Evanston, United States.
Michael R SchamberDepartment of Molecular Biosciences, Northwestern University, Evanston, United States.
Weifeng LuDepartment of Molecular Biosciences, Northwestern University, Evanston, United States.
Hamid Samareh AfsariDepartment of Molecular Biosciences, Northwestern University, Evanston, United States.ORCID 0000-0002-5839-4765
Reza VafabakhshDepartment of Molecular Biosciences, Northwestern University, Evanston, United States.ORCID 0000-0001-8384-3203

Funding

CELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1M
Quantitative analysis of metabotropic glutamate receptor activation and modulationR01GM140272 · NIGMS · NORTHWESTERN UNIVERSITY · PI VAFABAKHSH, REZA · 2020 to 2024
$1.7M
NIGMS NIH HHS R01 GM140272NIGMS NIH HHS T32 GM008061
6 · The paper itself

Abstract

Activation of G protein-coupled receptors (GPCRs) is an allosteric process. It involves conformational coupling between the orthosteric ligand binding site and the G protein binding site. Factors that bind at non-cognate ligand binding sites to alter the allosteric activation process are classified as allosteric modulators and represent a promising class of therapeutics with distinct modes of binding and action. For many receptors, how modulation of signaling is represented at the structural level is unclear. Here, we developed fluorescence resonance energy transfer (FRET) sensors to quantify receptor modulation at each of the three structural domains of metabotropic glutamate receptor 2 (mGluR2). We identified the conformational fingerprint for several allosteric modulators in live cells. This approach enabled us to derive a receptor-centric representation of allosteric modulation and to correlate structural modulation to the standard signaling modulation metrics. Single-molecule FRET analysis revealed that a NAM (egative allosteric modulator) increases the occupancy of one of the intermediate states while a positive allosteric modulator increases the occupancy of the active state. Moreover, we found that the effect of allosteric modulators on the receptor dynamics is complex and depend on the orthosteric ligand. Collectively, our findings provide a structural mechanism of allosteric modulation in mGluR2 and suggest possible strategies for design of future modulators.

Indexed as

Receptors, Metabotropic GlutamateAllosteric RegulationAllosteric SiteBinding SitesLigandsLigandsmetabotropic glutamate receptor 2Receptors, Metabotropic Glutamateallosteric modulationbiochemistrychemical biologyconformational dynamicsGPCRsmolecular biophysicsnonesingle-molecule FRETstructural biology

Identifiers

PMID35775730
PMCPMC9299836
OpenAlexW4283768825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.